Inositec has an extensive drug discovery platform based on analogs of inositol. Inositec will pursue development of its lead compounds to treat cardiovascular and renal calcification disorders through clinical proof-of-concept. The company is seeking to partner certain drug candidate and discovery assets and is open for discussions.

For further information on business development opportunities, contact